Correlation Between Iovance Biotherapeutics and Syros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Syros Pharmaceuticals, you can compare the effects of market volatilities on Iovance Biotherapeutics and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Syros Pharmaceuticals.
Diversification Opportunities for Iovance Biotherapeutics and Syros Pharmaceuticals
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Iovance and Syros is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Syros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Syros Pharmaceuticals
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.23 times more return on investment than Syros Pharmaceuticals. However, Iovance Biotherapeutics is 4.38 times less risky than Syros Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Syros Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 1,081 in Iovance Biotherapeutics on August 30, 2024 and sell it today you would lose (141.00) from holding Iovance Biotherapeutics or give up 13.04% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Iovance Biotherapeutics vs. Syros Pharmaceuticals
Performance |
Timeline |
Iovance Biotherapeutics |
Syros Pharmaceuticals |
Iovance Biotherapeutics and Syros Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iovance Biotherapeutics and Syros Pharmaceuticals
The main advantage of trading using opposite Iovance Biotherapeutics and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
Syros Pharmaceuticals vs. Surrozen | Syros Pharmaceuticals vs. Bolt Biotherapeutics | Syros Pharmaceuticals vs. Larimar Therapeutics | Syros Pharmaceuticals vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |